• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

Section Contents Menu


Record of Telephone Conversation - October 6, 2009 - Prevnar 13

System Info - 111933  SMITH, MICHAEL J  23-Nov-2009 18:05:12  SMITHM



Submission Type: Original Application   Submission ID:  125324/0    Office: OVRR  


Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein).


Wyeth Pharmaceuticals Inc.


Telecon Date/Time:  06-OCT-2009 11:04 AM               Initiated by FDA?  Yes

Telephone Number:    


Communication Categorie(s):

Information Request




Telecon Summary:

Email: IR for immunogenicity data for study 3005 and 008.


FDA Participants:   Julienne Vaillancourt, Tina Khoie and Michael Smith


Non-FDA Participants:    Carmel Devlin


Trans-BLA Group: No


Related STNs:  None


Related PMCs:  None


Telecon Body:



From:            Sweeney, Colleen 

Sent:             Tuesday, October 06, 2009 11:04 AM

To:                'DEVLINC@wyeth.com'

Cc:                Vaillancourt, Julienne; Khoie, Tina; Smith, Michael (CBER)

Subject:         RE:  Request for data submission to STN: 125324 previously submitted to IND 11673

Importance:    High


Dear Carmel:

In regard to the telephone message I had left earlier this morning I just wanted to follow up with an e-mail:

On July 15, 2009, amendment 229 was submitted to IND –(b)(4)-. This amendment contained the following data:

1) New immunogenicity data from study 3005, including pneumococcal NI data (comparison of data from 3 pooled 13vPnC lots to the 1 7vPnC lot), post infant and toddler doses.

2) Toddler dose immunogenicity data (OPA and IgG) from study 008 to support the transition schedule from 7vPnC to 13vPnC.

Please submit this data to STN: 125324.


Thank you,


Colleen Sweeney


End of email


Contact FDA

(800) 835-4709
(240) 402-8010
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

10903 New Hampshire Avenue

Building 71 Room 3103

Silver Spring, MD 20993-0002